AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
COH Share Price and JBH Performance: Developments in ASX Healthcare Stocks and Retail Sector
April 16, 2025 05:05 PM AEST| By Team Kalkine MediaHighlights:,COH share price has declined since the start of the year, drawing attention to its recent financial outcomes.,JBH revenue and net profit movements reflect broader trends in consumer electronics retailing.,Focus on,ASX Healthcare Stocks,su...
"Growth" Defines Firebrick's (ASX:FRE) Sales-Focused Quarter
April 16, 2025 03:30 PM AEST| By Team Kalkine MediaHighlights:,Firebrick Pharma expands its Nasodine product line across multiple global markets, including Singapore, the United States, and the South Pacific.,Key collaborations with local partners, such as Innorini Life Sciences and Makans, support t...
PainChek (ASX:PCK) Strengthens Growth Prospects with R&D Boost, FDA Progress, and Infant App Launch
April 16, 2025 03:16 PM AEST| By Team Kalkine MediaHighlights,$1.41M R&D tax refund extends financial runway,US FDA review of Adult App progressing steadily,Infant App launches with strong early reception,PainChek (ASX:PCK),is making notable strides in its mission to transform pain assessment through...
The Share Price of Althea Group Holdings Limited (ASX:AGH) Reflects Market Sentiment Regarding Its Revenues
April 16, 2025 02:33 PM AEST| By Team Kalkine MediaHighlights:,Althea Group Holdings exhibits a low price-to-sales ratio, reflecting its below-industry valuation.,The company has shown positive revenue growth, though it trails behind industry growth projections.,Investor sentiment indicates cautious...
Why Healthcare Tech is on the Radar: A Closer Look at Pro Medicus (ASX:PME)
April 16, 2025 02:10 PM AEST| By Team Kalkine MediaHighlights,PME delivers radiology tech that supports faster diagnostics,Healthcare sector offers stable revenue and long-term growth,PME trades at a premium valuation with rising revenue,Pro Medicus (ASX:PME), a leading healthcare technology provider...
PTX-100 Moves Closer to Market as FDA Grants Fast-Track Status to Prescient Therapeutics
April 16, 2025 01:46 PM AEST| By Team Kalkine MediaHighlights,PTX-100 receives fast-track status from FDA,Promising early results in treating T-cell lymphoma,Phase 2 trials underway across multiple regions,Prescient Therapeutics (ASX:PTX) has achieved a key regulatory milestone, with its lead drug ca...
NeuroScientific (ASX:NSB) Accelerates Stem Cell Advancements with Strategic Acquisition of Isopogen
April 16, 2025 01:32 PM AEST| By Team Kalkine MediaHighlights,NeuroScientific acquires Isopogen and its patented StemSmart technology,Focus on regenerative stem cell therapies for neurodegenerative disorders,New clinical trials planned to drive regulatory path forward,NeuroScientific Biopharmaceutica...
Tryptamine Therapeutics (ASX:TRP) Launches Groundbreaking Psilocybin Trial for Binge Eating Disorder
April 16, 2025 01:14 PM AEST| By Team Kalkine MediaHighlights,New trial with Swinburne University targets binge eating disorder,TRP-8803 infusion aims to assess impact on eating behavior, mental health,Builds on strong Phase 2 results from prior psilocybin studies,Tryptamine Therapeutics (ASX:TRP) ha...
FDA Fast Track Boosts Prescient’s PTX-100 Toward Commercialisation Milestone
April 16, 2025 11:11 AM AEST| By Team Kalkine MediaHighlights,PTX-100 granted Fast Track status by US FDA,Clinical-stage progress enhances commercial pathway,Phase 2 trial in CTCL advancing toward patient enrolment,Prescient Therapeutics (ASX:PTX) has taken a significant step forward in its oncology...
Shareholders Should Not Ignore Pro Medicus Insiders Selling AU$514 Million in Stock
April 15, 2025 10:30 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus Limited (PME) experienced a notable stock price increase of 20% last week.,Insider transactions have favored sales over purchases in the past year, raising interest and curiosity.,Insider ownership stands at 49%, promoting alig...
Navigating Volatile Markets with Quality ASX Healthcare Stocks and ETFs
April 15, 2025 03:40 PM AEST| By Team Kalkine MediaHighlights,Focus remains on established ASX 200 companies with strong fundamentals and resilient business models,Select ASX ETFs offer diversified exposure to global and local leaders across multiple sectors,Dividend-paying shares in consumer staples...
Clarity Pharmaceuticals and Key Developments in ASX Penny Stocks – April 2025
April 15, 2025 02:44 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals progresses in radiopharmaceutical research with a focus on prostate cancer,Deep Yellow advances uranium exploration efforts in Namibia and Australia,Stanmore Resources experiences fluctuations in revenue and earning...
Pro Medicus signs R&D agreement with UCSF for Visage AI Accelerator
April 15, 2025 02:30 PM AEST| By Team Kalkine MediaHighlights:,Pro Medicus partners with University of California San Francisco to advance AI in medical imaging.,The collaboration aims to enhance the Visage AI Accelerator platform's capabilities.,The partnership emphasizes the integration of clinical...
Resilience in Focus: CSL and ResMed Stand Out Amid Tariff Concerns
April 15, 2025 02:13 PM AEST| By Team Kalkine MediaHighlights,CSL and ResMed seen as strong performers under tariff pressures,Healthcare stocks show strength during past market downturns,Fundamental growth supports CSL and ResMed’s long-term positioning,As global markets prepare for the potential imp...
ASX Inches Up as Miners and Tech Lift Market Amid Global Uncertainty
April 15, 2025 12:36 PM AEST| By Team Kalkine MediaHighlights,ASX 200 sees mild gains despite choppy session,Mining and tech stocks lead the upward move,Caution lingers due to US tariff policy concerns,The Australian sharemarket saw a modest rise in early trade, continuing to navigate a cautious envi...
Clarity Pharmaceuticals (ASX:CU6) Advances Cancer Therapy with Phase II Trial Milestone
April 15, 2025 12:31 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals begins Phase II cohort expansion in,SECuRE,trial,First patient treated with 8,GBq,dose of improved radiopharmaceutical,New formulation enhances stability and scalability for future trials,Clarity Pharmaceuticals (AS...
4DMedical Expands Reach with New Commercial Contract for Lung Imaging Technology
April 15, 2025 12:29 PM AEST| By Team Kalkine MediaHighlights,4DMedical signs new commercial contract with Integral Diagnostics,Advanced lung imaging tech expands to more clinics across Victoria,Continued success converting pilots into commercial deals,4DMedical (ASX:4DX), a leading innovator in medi...
ASX Market Close: Elixir Surges with Neil Young's Resignation; US Futures Show Growth & More
April 14, 2025 05:30 PM AEST| By Team Kalkine MediaHighlights,Technology sector on the ASX leads with strong gains following positive trends from international markets.,Materials sector shows growth due to rising commodity prices, particularly iron ore and gold.,Key companies like Droneshield, Neuren...
Orthocell Ltd Advances with FDA Clearance for Remplir™ and Market Expansion
April 14, 2025 04:21 PM AEST| By Team Kalkine MediaHighlights,FDA clearance granted for Orthocell’s Remplir™ nerve repair device, facilitating entry into the nerve repair market.,Significant growth in revenue with expanded manufacturing capabilities for global distribution.,Orthocell added to the S&P...
Visionflex Partners with Amplar on $1M Telehealth Initiative to Revolutionise Aged Care Access
April 14, 2025 12:34 PM AEST| By Team Kalkine MediaHighlights,Visionflex,and,Amplar,launch $1m telehealth initiative for aged care,Pilot to serve 30 residential aged care homes across Australia,Focus on virtual nursing and,personalised,clinical care,Visionflex Group (ASX:VFX) has announced a strategi...
Advertise your brand on Kalkine Media